Navigation Links
Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX)

NATICK, Mass., April 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has been named U.S. Healthcare Supplier of the Year in the GHXcellence Awards for achievements in improving supply chain performance. The award recognizes Boston Scientific's successful use of electronic transactions to improve supply chain efficiency for customers and suppliers.

The annual awards were granted by GHX based on application of the following criteria to an organization's performance during the 2007 calendar year:
-- Increased use of e-commerce solutions throughout the healthcare supply


-- Number of trading partners with whom they conduct e-commerce

-- Percentage of orders transacted electronically

-- Percentage of invoices transacted electronically

-- Reduction in order and invoice discrepancies and errors

Boston Scientific has implemented numerous e-commerce transaction options, including electronic order placement, electronic invoicing, advance shipping notices and electronic catalogs. Currently, more than 80 percent of the Company's domestic customers employ Electronic Data Interchange (EDI) to facilitate business transactions. EDI is the electronic transfer of structured data in a standard format between businesses, organizations or other groups.

"This award acknowledges our commitment to the use of e-commerce to improve efficiency and reduce costs throughout the supply chain," said Paul LaViolette, Boston Scientific Chief Operating Officer. "Through process and software system improvements, we have been able to expand our electronic offerings and increase transaction efficiency and customer satisfaction."

"This year's GHXcellence Awards honor providers and suppliers that have taken steps to maximize utilization of e-commerce solutions across their organizations," said GHX President Bruce Johnson. "By optimizing business processes and the use of technology, they are demonstrating how healthcare organizations can lower costs and improve operational performance."

The award was presented by GHX on Friday, April 18, 2008 during a recognition ceremony in Chicago at the 8th Annual GHX Supply Chain Summit.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit:

About GHX

GHX enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making. Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. For more information, visit

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our supply chain management and our growth strategy. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACT: Paul Donovan

508-650-8541 (office)

508-667-5165 (mobile)

Media Relations

Boston Scientific Corporation

Larry Neumann

508-650-8696 (office)

Investor Relations

Boston Scientific Corporation

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
2. DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
3. Boston Trial to Test New HIV/AIDS Vaccine
4. Boston College biologists build a better mouse model for cancer research
5. Every Boston Red Sox Home Run Televised on NESN in 2008 to Help Children With Medical Needs
6. Boston Scientific Announces Appointment of Timothy Pratt as General Counsel
7. Boston Kids Enjoy Free Davis Vision Screenings
8. Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution
9. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
10. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
11. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
(Date:11/27/2015)... ... 2015 , ... The moment you stop improving is the ... the needs of advisers and clients but going above and beyond to find ... service. However, there's always room for improvement, which is why the entire Consulting ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... 2015 , ... Dr. Thomas Dunlap and Dr. Patrick Coleman ... with Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , ... in similar ways and require time-critical intervention to avoid large area heart damage and ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
(Date:11/26/2015)... ... 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday sales ... Black Friday and Cyber Monday massage chair sales to receive the best ... low to find the best massage chair deals, they can see all of the ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 AAIPharma Services Corp./Cambridge Major Laboratories, ... least $15.8  Million to expand its laboratories and ... . The expansion will provide additional office space ... demands of the pharmaceutical and biotechnology markets. ... provide up to 40,000 square feet of expanded ...
(Date:11/25/2015)... , Nov. 25, 2015  ARKRAY USA ... continues to provide evidence demonstrating the accuracy of its ... Congress on Insulin Resistance, Diabetes and Cardiovascular Disease in ... both the Company,s GLUCOCARD ® 01 meter and ... accuracy requirements. The ability to accurately measure glucose levels ...
(Date:11/25/2015)... 25, 2015 Kitov Pharma ... KTOV), a biopharmaceutical company focused on the development of ... conditions, today announced the closing of its previously announced ... ADSs ), each representing 20 ordinary shares of the ... The ADSs and warrants were issued in a fixed ...
Breaking Medicine Technology: